Fidji Simo, the CEO of AGI Deployment at OpenAI, is stepping down from her full-time position effective immediately, following an extended three-month medical leave. The high-profile technology executive, who joined the artificial intelligence company in 2025, will transition into a part-time advisory role to support the company as it navigates its next phase of corporate growth.
Health Challenges And Leadership Transition
Simo’s departure comes after a severe exacerbation of a chronic neuroimmune condition, specifically postural orthostatic tachycardia syndrome (POTS), which necessitated her departure from daily operations. In a statement addressing her medical leave, Simo confirmed: “Three months ago, I had to go on medical leave after a severe exacerbation of a chronic illness I’ve lived with.”
Strategic Impact On OpenAI Operations
Initially recruited to lead the company’s applications division, Simo was instrumental in efforts to scale OpenAI’s product offerings and integrate business operations as the firm aimed to solidify its position as a global software powerhouse. Her transition follows a period of internal restructuring at the organisation, which has seen shifts in product team leadership as the company prepares for its long-term strategic objectives and potential future market activity. Development of future product strategies at OpenAI will continue under the remaining executive leadership team as they refine the deployment of AGI technology.